ID: ALA4105501

Max Phase: Preclinical

Molecular Formula: C14H10N4O

Molecular Weight: 250.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1ccc2ccccc2n1)c1cncnc1

Standard InChI:  InChI=1S/C14H10N4O/c19-14(11-7-15-9-16-8-11)18-13-6-5-10-3-1-2-4-12(10)17-13/h1-9H,(H,17,18,19)

Standard InChI Key:  PRDQBNCHOUTCHR-UHFFFAOYSA-N

Associated Targets(non-human)

MDCK-II 565 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 250.26Molecular Weight (Monoisotopic): 250.0855AlogP: 2.28#Rotatable Bonds: 2
Polar Surface Area: 67.77Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.56CX Basic pKa: 2.10CX LogP: 1.89CX LogD: 1.89
Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.76Np Likeness Score: -1.56

References

1. Siddiqui-Jain A, Hoj JP, Hargiss JB, Hoj TH, Payne CJ, Ritchie CA, Herron SR, Quinn C, Schuler JT, Hansen MDH..  (2017)  Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms.,  27  (17): [PMID:28780159] [10.1016/j.bmcl.2017.07.063]

Source